Tiziana Life Sciences Ltd. Common Shares (TLSA) is a publicly traded Healthcare sector company. As of September 17, 2026, TLSA trades at $0.88 with a market cap of $108.42M and a P/E ratio of 0.00. TLSA moved +13.88% today. Year to date, TLSA is -48.32%; over the trailing twelve months it is -53.89%. Its 52-week range spans $0.63 to $2.60. Analyst consensus is moderatebuy with an average price target of $7.00. Rallies surfaces TLSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for TLSA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $0.88 |
| Market Cap | $108.42M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $2.60 |
| 52-Week Low | $0.63 |
| Volume | 168.98K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
1 analysts cover TLSA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $7.00.